Wyden Unveils Findings of Pfizer Tax Dodging Investigation
Washington, D.C. – Continuing his ongoing investigation of drug company tax avoidance, Senate Finance Committee Ranking Member Ron Wyden, D-Ore., unveiled new findings specific to tax dodging by the company Pfizer. In 2019, Pfizer sold $20 billion worth of drugs to American patients, but the company reported zero taxable U.S. profits by claiming 100 percent […]
Wyden Statement on Mass Layoffs and Restructuring at Department of Health and Human Services
Washington, D.C. — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement after Robert F. Kennedy Jr., secretary of the Department of Health and Human Services (HHS) announced mass layoffs and restructuring at the agency. “American families are going to be hurt by layoffs and closures of this magnitude, full stop,” […]
Wyden Opposes Faulkender Nomination
The Senate will soon take a vote on the nomination of Michael Faulkender to serve as Deputy Treasury Secretary. I urge my colleagues to oppose this nomination, and I want to explain why he got zero support from Democrats in the Finance Committee. Let’s start out with the big picture. For the last two months, […]
WATCH: Wyden Blasts Trump Social Security Nominee for Lying Over DOGE Connections, Following Whistleblower Statement
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today blasted Frank Bisignano, Donald Trump’s nominee to lead the Social Security Administration, after a whistleblower statement provided to Wyden’s office showed Bisignano lied about his connections to DOGE and its efforts to break Social Security. Wyden also sounded the alarm on Trump and […]
Wyden Investigation Finds Rapid Growth in Spending on Marketing Middlemen Among Medicare Advantage Plans
Text of the Report (PDF) Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released an investigation into the marketing practices of health insurance companies that sell Medicare Advantage plans, with a focus on third-party marketing organizations (TPMOs) that insurers are increasingly employing to maximize the number of American seniors enrolled in […]
Wyden Statement at Finance Committee Hearing to Consider Nomination of Frank Bisignano to Lead Social Security
This morning the Finance Committee gathers to discuss the future of the Social Security Administration and its potential new leader, Frank Bisignano. Today’s news brings fresh reports that it’s bedlam out there in Social Security. That’s what I heard last week from senior Social Security staffers at a town hall meeting I arranged for federal […]
Wyden Statement at Finance Committee Markup of Dr. Oz to be CMS Administrator
Later today, this Committee will vote on Dr. Oz’s nomination. I’m going to spend a few minutes explaining why I cannot support his nomination. During his confirmation hearing, Dr. Oz was given the chance to assure the American people that he would not be a rubber stamp for Republicans’ plans to gut Medicaid and hike […]
Wyden Statement on Debt Ceiling Projection
Washington, D.C. — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement on the Bipartisan Policy Center’s new projection that the U.S. could default on its debt as soon as July: “The economic agenda for Trump and Republicans is about running up the debt and inflicting pain on working families to […]
Wyden Delivers Remarks and Asks Unanimous Consent to Pass the Bipartisan Health Care Act
Watch a video of Wyden deliver his remarks here I come to the Senate floor today to pass a set of critical improvements to America’s health care system. This legislation is overwhelmingly bipartisan, fully paid for, and targeted at two objectives every Senator should support: improving health care for Americans and cracking down on middlemen […]
Wyden Statement at Finance Committee Nomination Hearing of Dr. Mehmet Oz to Lead CMS
Dr. Mehmet Oz is nominated to oversee the Centers for Medicare & Medicaid Services, which is responsible for the health and well-being of over 160 million Americans. Once again, our dedicated investigators on the Finance Committee have brought the receipts. Dr. Oz is the second Trump nominee to come before the Finance Committee this year […]